Dimensional Fund Advisors LP Longboard Pharmaceuticals, Inc. Transaction History
Dimensional Fund Advisors LP
- $363 Billion
- Q1 2024
A detailed history of Dimensional Fund Advisors LP transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 19,974 shares of LBPH stock, worth $630,778. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,974
Previous 32,747
39.01%
Holding current value
$630,778
Previous $197,000
118.78%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LBPH
# of Institutions
106Shares Held
30MCall Options Held
16.3KPut Options Held
56.5K-
Cormorant Asset Management, LP Boston, MA3.35MShares$106 Million4.17% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.94MShares$92.9 Million0.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.22MShares$70 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.14MShares$67.5 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.87MShares$58.9 Million0.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $429M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...